← All indications
Bone Marrow Failure Disorders
Inherited or acquired diseases characterized by insufficient and/or dysplastic blood cells.
Subtype terms (2)
More specific conditions that are subtypes of Bone Marrow Failure Disorders in the MeSH hierarchy.
- Anemia, Aplastic
105 drugs (64 approved, 41 experimental)
- Congenital Bone Marrow Failure Syndromes
10 drugs (9 approved, 1 experimental)
Drugs by status
Phase 2 trials (36)
- methylprednisolone
- plerixafor
- busulfan
- clofarabine
- prednisone
- eltrombopag
- tacrolimus
- lymphocyte immune globulin, anti-thymocyte globulin (equine)
- hemopoietic stem cell
- bone marrow derived mesenchymal stem cells
- haploidentical mononuclear cells
- hydroxyurea
- Filgrastim
- pembrolizumab
- levamisole
- ibrutinib
- sirolimus
- cyclosporine
- mycophenolate
- t cell depleted hematopoietic stem cells
- alemtuzumab
- nandrolone phenpropionate
- allogeneic cord blood
- autologous cd34+ cells
- autologous umbilical cord blood
- umbilical cord mesenchymal stem cells
- cd45-depleted allogenic peripheral blood stem cell
- mesna
- methotrexate
- rituximab
- +6 more
Phase 1 trials (7)